About: Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 30 December 2014

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2014 (uk) im Januar 2014 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 30 December 2014 (en) artículu científicu espublizáu n'avientu de 2014 (ast)
publication date	wds:Q59101206-5CB9AD92-E8A0-46E4-81F9-2D7B6B56F2D4
publication date	2014-12-30 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59101206-50D65B72-B4F0-475B-A00A-8BAD22B9F5BC
language of work or name	English
cites work	wds:Q59101206-089696C3-B2E4-4D9C-A352-0EC7A877C1C1 wds:Q59101206-137D7674-F08E-409F-906E-3C9178249239 wds:Q59101206-17724CD4-3D47-45F2-ABEE-0B9E741EF384 wds:Q59101206-1A52838C-7CC7-4E8C-9025-20A5316EA724 wds:Q59101206-25C36779-2463-4B5F-956B-F897DC0FB61E wds:Q59101206-28DBB1E5-89BE-41C7-9EFB-A1EB884AB74F wds:Q59101206-315E0CD6-5D2F-4A80-BD14-C0FA9D6490FB wds:Q59101206-34441328-EEC5-4C86-A38B-0EC652BD977B wds:Q59101206-3A79F5A4-CE82-4C13-90D3-84EEF27A84C6 wds:Q59101206-460139FA-DE9D-483F-AD74-4BFFF3617B39 wds:Q59101206-498CC2FB-8FE1-4446-9DF6-D6892E40AC4B wds:Q59101206-4F40E8C7-3852-4828-B055-111CF894CBEE wds:Q59101206-54BEA211-F8C0-42F7-B745-E577445F656F wds:Q59101206-5E6C42B1-2BC6-4FE7-911C-C50DEA586A9A wds:Q59101206-6587589B-8A15-4588-A67E-CE171870F0CC wds:Q59101206-7501B525-513C-4182-B738-DD6BE64AB42C wds:Q59101206-884B9D69-DFA2-428F-9C17-358D33E08567 wds:Q59101206-939C12BA-AE64-4FF5-BDB8-9CAAE99DFD0D wds:Q59101206-977494EA-2729-459A-8A02-CA8780C6A23E wds:Q59101206-A0F6E513-C329-4844-8C27-E4CB9EDC6324 wds:Q59101206-A4BBB8A8-59F1-44A8-A8FE-68F9CA8C7446 wds:Q59101206-AE25CD77-F6E2-4AE5-9C65-142986288681 wds:Q59101206-B6AE76E6-5409-446F-B515-342A50FB0410 wds:Q59101206-BB399DAC-6D6D-41DB-91C3-00B5615C321F wds:Q59101206-BD5897C7-A01A-47BC-B334-719E364A6DA3 wds:Q59101206-CA5FC1FD-17CF-43BE-96F1-B0AE8287D61C wds:Q59101206-CB37A75E-3C44-42B5-9A1B-EEEAE16ADB3D wds:Q59101206-D07A9346-2EE3-4462-9A8A-A7CCFF804D6B wds:Q59101206-D1FECCEB-239E-441A-BFAA-096A8B5D24D3 wds:Q59101206-D2A136DB-7312-4EE1-9088-36769E9019D4 wds:Q59101206-D9ED74AD-E70C-4A41-AB94-93F2C0B87F72 wds:Q59101206-E3EA8700-254D-40EF-9A7F-DFCCAF18D1E8 wds:Q59101206-E484F31F-E511-4A64-981E-7D1709C1FE8F wds:Q59101206-E7CD92FF-DFD6-4FED-96B9-D8073910EEFA wds:Q59101206-E87070DC-68A4-4BE1-A5CC-A4695FCEB398 wds:Q59101206-EC583A83-89CB-4748-847C-E63C508461F8 wds:Q59101206-EE98DECC-636D-4860-A36E-B89D1D642F08 wds:Q59101206-F7D3DF10-A0F3-4C4F-947D-998F3C08A402 wds:Q59101206-F830AB08-4A44-4996-B46F-E35EA1F41BDC wds:Q59101206-FACC82FE-9F62-41F7-A7D8-EB3478049F21
cites work	Comparison of the pharmacodynamics of imipenem in patients with ventilator-associated pneumonia following administration by 2 or 0.5 h infusion. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. Incidence and bacteriology of burn infections at a military burn center Acinetobacter baumannii: emergence of a successful pathogen OXA-type carbapenemases in Acinetobacter baumannii in South America. Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections Update on bacterial nosocomial infections. Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams Mutant selection window hypothesis updated. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology Metallo-beta-lactamases: the quiet before the storm? Detection of KPC in Acinetobacter spp. in Puerto Rico Global spread of carbapenem-resistant Acinetobacter baumannii Pharmacodynamics: relation to antimicrobial resistance Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula Clinically significant carbapenemases: an update. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem Stretching the mutant prevention concentration (MPC) beyond its limits Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates Can PK/PD be used in everyday clinical practice Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. Mutant prevention concentrations of four carbapenems against gram-negative rods The use of carbapenems in the treatment of serious infections Prevalence of inducible AmpC beta-lactamase-producing Pseudomonas aeruginosa in a tertiary care hospital in northern India Pharmacodynamics of cefepime in patients with Gram-negative infections Study of the multidrug membrane transporter of single living Pseudomonas aeruginosa cells using size-dependent plasmonic nanoparticle optical probes Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China Antimicrobial resistance among pathogenic bacteria in Southeast Asia [Antibacterial drug resistance in Latin America: consequences for infectious disease control] In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa. A simple screening test for the detection of metallo-β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter in a tertiary care hospital Mutant Prevention Concentration: is it significant in the clinical practice? Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains
author name string	wds:Q59101206-0528E978-9100-4BD4-ABB8-014D6A1BB334 wds:Q59101206-0871E1A2-6F15-4DBB-8BF6-ED9715064AFE wds:Q59101206-8B178E45-1C4C-4360-894E-BACC933DE25B
author name string	E Dahdouh S E Salem S H Shoucair
rdfs:label	Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii (en) Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii (nl)
skos:prefLabel	Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii (en) Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software